Costimulatory Molecule DNAM-1 Is Essential for Optimal Differentiation of Memory Natural Killer Cells during Mouse Cytomegalovirus Infection

Immunity

Volumn 40, Issue 2, 2014, Pages 225-234

  Nabekura, Tsukasa ^a   Kanaya, Minoru ^b   Shibuya, Akira ^b   Fu, Guo ^c   Gascoigne, Nicholas R J ^c,d   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL DIFFERENTIATION; CYTOMEGALOVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MUROMEGALOVIRUS;

CELL PROTEIN; DNAX ACCESSORY MOLECULE 1; PROTEIN KINASE C ETA; PROTEIN KINASE FYN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; IN VIVO STUDY; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 84894261203     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.12.011     Document Type: Article

References (56)

1. Aoki J., Koike S., Asou H., Ise I., Suwa H., Tanaka T., Miyasaka M., Nomoto A. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp. Cell Res. 1997, 235:374-384.
2. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
3. Bakker A.B., Hoek R.M., Cerwenka A., Blom B., Lucian L., McNeil T., Murray R., Phillips L.H., Sedgwick J.D., Lanier L.L. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 2000, 13:345-353.
4. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S., Reymond N., et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J.Exp. Med. 2003, 198:557-567.
5. Brown M.G., Dokun A.O., Heusel J.W., Smith H.R., Beckman D.L., Blattenberger E.A., Dubbelde C.E., Stone L.R., Scalzo A.A., Yokoyama W.M. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 2001, 292:934-937.
6. Bubić I., Wagner M., Krmpotić A., Saulig T., Kim S., Yokoyama W.M., Jonjić S., Koszinowski U.H. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J.Virol. 2004, 78:7536-7544.
7. Cicin-Sain L., Podlech J., Messerle M., Reddehase M.J., Koszinowski U.H. Frequent coinfection of cells explains functional invivo complementation between cytomegalovirus variants in the multiply infected host. J.Virol. 2005, 79:9492-9502.
8. Cooper M.A., Elliott J.M., Keyel P.A., Yang L., Carrero J.A., Yokoyama W.M. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 2009, 106:1915-1919.
9. Dardalhon V., Schubart A.S., Reddy J., Meyers J.H., Monney L., Sabatos C.A., Ahuja R., Nguyen K., Freeman G.J., Greenfield E.A., et al. CD226 is specifically expressed on the surface of Th1 cells and regulates their expansion and effector functions. J.Immunol. 2005, 175:1558-1565.
10. Dokun A.O., Kim S., Smith H.R., Kang H.S., Chu D.T., Yokoyama W.M. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2001, 2:951-956.
11. Fodil-Cornu N., Lee S.H., Belanger S., Makrigiannis A.P., Biron C.A., Buller R.M., Vidal S.M. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J.Immunol. 2008, 181:6394-6405.
12. Foley B., Cooley S., Verneris M.R., Curtsinger J., Luo X., Waller E.K., Anasetti C., Weisdorf D., Miller J.S. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand invivo in response to recipient CMV antigen. J.Immunol. 2012, 189:5082-5088.
13. Foley B., Cooley S., Verneris M.R., Pitt M., Curtsinger J., Luo X., Lopez-Vergès S., Lanier L.L., Weisdorf D., Miller J.S. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012, 119:2665-2674.
14. Fu G., Hu J., Niederberger-Magnenat N., Rybakin V., Casas J., Yachi P.P., Feldstein S., Ma B., Hoerter J.A., Ampudia J., et al. Protein kinase C η is required for Tcell activation and homeostatic proliferation. Sci. Signal. 2011, 4:ra84.
15. Gilfillan S., Chan C.J., Cella M., Haynes N.M., Rapaport A.S., Boles K.S., Andrews D.M., Smyth M.J., Colonna M. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J.Exp. Med. 2008, 205:2965-2973.
16. Henry S.C., Schmader K., Brown T.T., Miller S.E., Howell D.N., Daley G.G., Hamilton J.D. Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J.Virol. Methods 2000, 89:61-73.
17. Hsu K.M., Pratt J.R., Akers W.J., Achilefu S.I., Yokoyama W.M. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J.Gen. Virol. 2009, 90:33-43.
18. Iguchi-Manaka A., Kai H., Yamashita Y., Shibata K., Tahara-Hanaoka S., Honda S., Yasui T., Kikutani H., Shibuya K., Shibuya A. Accelerated tumor growth in mice deficient in DNAM-1 receptor. J.Exp. Med. 2008, 205:2959-2964.
19. Kamran N., Takai Y., Miyoshi J., Biswas S.K., Wong J.S., Gasser S. Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells. PLoS ONE 2013, 8:e54406.
20. König S., Nimtz M., Scheiter M., Ljunggren H.G., Bryceson Y.T., Jänsch L. Kinome analysis of receptor-induced phosphorylation in human natural killer cells. PLoS ONE 2012, 7:e29672.
21. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
22. Lee S.H., Girard S., Macina D., Busà M., Zafer A., Belouchi A., Gros P., Vidal S.M. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 2001, 28:42-45.
23. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011, 108:14725-14732.
24. Lowin-Kropf B., Kunz B., Schneider P., Held W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 2002, 32:773-782.
25. Mason L.H., Willette-Brown J., Taylor L.S., McVicar D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J.Immunol. 2006, 176:6615-6623.
26. Min-Oo G., Kamimura Y., Hendricks D.W., Nabekura T., Lanier L.L. Natural killer cells: walking three paths down memory lane. Trends Immunol. 2013, 34:251-258.
27. Nabekura T., Otsu M., Nagasawa T., Nakauchi H., Onodera M. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. Mol. Ther. 2006, 13:301-309.
28. Nabekura T., Shibuya K., Takenaka E., Kai H., Shibata K., Yamashita Y., Harada K., Tahara-Hanaoka S., Honda S., Shibuya A. Critical role of DNAX accessory molecule-1 (DNAM-1) in the development of acute graft-versus-host disease in mice. Proc. Natl. Acad. Sci. USA 2010, 107:18593-18598.
29. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 2006, 7:507-516.
30. Paust S., Gill H.S., Wang B.Z., Flynn M.P., Moseman E.A., Senman B., Szczepanik M., Telenti A., Askenase P.W., Compans R.W., von Andrian U.H. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 2010, 11:1127-1135.
31. Pende D., Castriconi R., Romagnani P., Spaggiari G.M., Marcenaro S., Dondero A., Lazzeri E., Lasagni L., Martini S., Rivera P., et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 2006, 107:2030-2036.
32. Prod'homme V., Sugrue D.M., Stanton R.J., Nomoto A., Davies J., Rickards C.R., Cochrane D., Moore M., Wilkinson G.W., Tomasec P. Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112. J.Gen. Virol. 2010, 91:2034-2039.
33. Ravens I., Seth S., Förster R., Bernhardt G. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. Biochem. Biophys. Res. Commun. 2003, 312:1364-1371.
34. Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev. 2009, 228:9-22.
35. Schlub T.E., Sun J.C., Walton S.M., Robbins S.H., Pinto A.K., Munks M.W., Hill A.B., Brossay L., Oxenius A., Davenport M.P. Comparing the kinetics of NK cells, CD4, and CD8 Tcells in murine cytomegalovirus infection. J.Immunol. 2011, 187:1385-1392.
36. Seddon B., Zamoyska R. TCR signals mediated by Src family kinases are essential for the survival of naive Tcells. J.Immunol. 2002, 169:2997-3005.
37. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanahan T., Kitamura T., Nicholl J., Sutherland G.R., Lanier L.L., Phillips J.H. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996, 4:573-581.
38. Shibuya A., Lanier L.L., Phillips J.H. Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J.Immunol. 1998, 161:1671-1676.
39. Shibuya K., Lanier L.L., Phillips J.H., Ochs H.D., Shimizu K., Nakayama E., Nakauchi H., Shibuya A. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 1999, 11:615-623.
40. Shirakawa J., Shibuya K., Shibuya A. Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). Int. Immunol. 2005, 17:217-223.
41. Shirakawa J., Wang Y., Tahara-Hanaoka S., Honda S., Shibuya K., Shibuya A. LFA-1-dependent lipid raft recruitment of DNAM-1 (CD226) in CD4+ Tcell. Int. Immunol. 2006, 18:951-957.
42. Sjölin H., Tomasello E., Mousavi-Jazi M., Bartolazzi A., Kärre K., Vivier E., Cerboni C. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J.Exp. Med. 2002, 195:825-834.
43. Smith K.M., Wu J., Bakker A.B., Phillips J.H., Lanier L.L. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J.Immunol. 1998, 161:7-10.
44. Smith H.R., Heusel J.W., Mehta I.K., Kim S., Dorner B.G., Naidenko O.V., Iizuka K., Furukawa H., Beckman D.L., Pingel J.T., et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 2002, 99:8826-8831.
45. Srinivas S., Watanabe T., Lin C.S., William C.M., Tanabe Y., Jessell T.M., Costantini F. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 2001, 1:4.
46. Stein P.L., Lee H.M., Rich S., Soriano P. pp59fyn mutant mice display differential signaling in thymocytes and peripheral Tcells. Cell 1992, 70:741-750.
47. + Tcells. Nat. Rev. Immunol. 2011, 11:645-657.
48. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457:557-561.
49. Sun J.C., Beilke J.N., Lanier L.L. Immune memory redefined: characterizing the longevity of natural killer cells. Immunol. Rev. 2010, 236:83-94.
50. Sun J.C., Lopez-Verges S., Kim C.C., DeRisi J.L., Lanier L.L. NK cells and immune "memory". J.Immunol. 2011, 186:1891-1897.
51. Sun J.C., Madera S., Bezman N.A., Beilke J.N., Kaplan M.H., Lanier L.L. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J.Exp. Med. 2012, 209:947-954.
52. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2004, 101:3516-3521.
53. Tahara-Hanaoka S., Shibuya K., Onoda Y., Zhang H., Yamazaki S., Miyamoto A., Honda S., Lanier L.L., Shibuya A. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 2004, 16:533-538.
54. Tahara-Hanaoka S., Shibuya K., Kai H., Miyamoto A., Morikawa Y., Ohkochi N., Honda S., Shibuya A. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor. Blood 2006, 107:1491-1496.
55. Tassi I., Cella M., Presti R., Colucci A., Gilfillan S., Littman D.R., Colonna M. NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood 2008, 112:4109-4116.
56. Tomasec P., Wang E.C., Davison A.J., Vojtesek B., Armstrong M., Griffin C., McSharry B.P., Morris R.J., Llewellyn-Lacey S., Rickards C., et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 2005, 6:181-188.